Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215 · Suffolk County
General Acute
At a glance
Latest cost report FY2024
Net patient revenue
$2.59B
Operating margin
-29.2%
Net income
$256.7M
Staffed beds
30
Annual discharges
1,299
Ownership & identity
Control, system & affiliation
Ownership / controlNonprofit (other) Health system— Hospital typeGeneral Acute Phone— CMS star rating— Emergency services—
Net patient revenue trend
FY2019–FY2024
| Fiscal year | Net patient revenue |
|---|---|
| FY2019 | $1,263,292,503 |
| FY2020 | $1,282,161,936 |
| FY2021 | $1,564,179,491 |
| FY2022 | $1,883,616,165 |
| FY2023 | $2,258,328,395 |
| FY2024 | $2,593,981,332 |
Payer mix
Share of inpatient days
Medicare34.0%Medicaid1.4%Commercial & other64.6%
How Dana-Farber Cancer Institute compares
#3 of 90 Massachusetts hospitals by net patient revenue
Full financial detail
Premium · in the Hospitals app
🔒 5-year income statement & balance sheet
Line-by-line revenue, expenses, assets, liabilities and net assets for FY2020–FY2024, plus top Medicare DRGs, cost structure, EBITDAR, and Medicare reimbursement (IME, DSH, charity & uncompensated care).
Open in the Hospitals app → 🔒 Screener & comparison builder
Screen all 6,421 U.S. hospitals, benchmark Dana-Farber Cancer Institute against Massachusetts peers on margin, revenue, occupancy and payer mix, build side-by-side comparisons, and export — in the interactive app.
Open the benchmarking tool →